Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia

American Journal of Geriatric Psychiatry

Volumn 20, Issue 1, 2012, Pages 61-72

  Ujkaj, Manjola ^a   Davidoff, Donald A ^b   Seiner, Stephen J ^b   Ellison, James M ^b   Harper, David G ^b   Forester, Brent P ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

aggression; agitation; BPSD; dementia; ECT; elderly; electroconvulsive therapy

Indexed keywords

ALPRAZOLAM; CHLORPROMAZINE; CITALOPRAM; CLONIDINE; CLOZAPINE; DONEPEZIL; DRONABINOL; ESCITALOPRAM; GABAPENTIN; GALANTAMINE; HALOPERIDOL; HALOPERIDOL DECANOATE; LITHIUM; LORAZEPAM; MEMANTINE; METHADONE; MIRTAZAPINE; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; SERTRALINE; TRAZODONE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VENLAFAXINE; ZIPRASIDONE;

AGGRESSION; AGITATION; ALZHEIMER DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; CONFUSION; DEMENTIA; ELECTROCONVULSIVE THERAPY; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MALE; MEDICAL RECORD REVIEW; MULTIINFARCT DEMENTIA; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; REVIEW; SAFETY; TREATMENT OUTCOME;

EID: 84155178085     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3182051bbc     Document Type: Article

References (48)

1. Cohen-Mansfield J: Nonpharmacologic interventions for inappropriate behaviors in dementia: a review, summary, and critique. Am J Geriatr Psychiatry 2001; Fall;9(4):361-381
2. Bartels SJ, Horn SD, Smout RJ, et al: Agitation and depression in frail nursing home elderly patients with dementia: treatment characteristics and service use. Am J Geriatr Psychiatry 2003; 11(2):231-238
3. Lyketsos CG, Lopez O, Jones B, et al: Prevalence of neu-ropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002; 288(12):1475-1483
4. Madhusoodanan S: Introduction: antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychi-atric patients. Am J Geriatr Psychiatry 2001; 9(3):283-288
5. Norton LE, Malloy PF, Salloway S: The impact of behavioral symptoms on activities of daily living in patients with dementia. Am J Geriatr Psychiatry 2001; 9(1):41-48
6. Salzman C, Jeste DV, Meyer RE, et al: Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry 2008; 69(6): 889-898
7. Alexopoulos GS, Jeste DV, Chung H, et al: Treatment of dementia and its behavioral disturbances. The expert Consensus Guideline Series. Postgrad Med 2005; Spec No:1-111
8. Sink KM, Holden KF, Yaffe K: Pharmacologic treatment of Neuropsychiatric symptoms of dementia. JAMA 2005; 293(5): 596-608
9. Schneider LS, Dagerman K, Insel PS: Efficacy and adverse effects of atypical antipsychotics fodementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006; 14(3):191-210
10. Schneider LS, Tariot PN, Dagerman KS, et al: CATIE-AD Study Group: Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 2006; 355(15): 1525-1538
11. Sultzer DL, Davis SM, Tariot PN, et al; CATIE-AD Study Group: Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry 2008; 165(7):844-854
12. Greenberg RM, Kellner CH: Electroconvulsive therapy: a selected review. Am J Geriatr Psychiatry 2005; 13(4):268-281
13. Mukherjee S, Sackeim HA, Schnur DB: Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry 1994; 151(2):169-176
14. Kramer BA: ECT in elderly patients with schizophrenia. Am J Geriatr Psychiatry 1999; 7(2):171-174
15. Suzuki K, Awata S, Takano T, et al: Continuation electroconvul-sive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia. Psychiatry Clin Neurosci 2005; 59(4):481-489
16. Kennedy R, Mittal D, O'Jile J: Electroconvulsive therapy in movement disorders: an update. J Neuropsychiatry Clin Neurosci 2003; 15(4):407-421
17. Philibert RA, Richards L, Lynch CF, et al: Effect of ECT on mortality and clinical outcome in geriatric unipolar depression. J Clin Psychiatry 1995; 56(9):390-394
18. Wilkins KM, Ostroff R, Tampi RR: Efficacy of electroconvulsive therapy in the treatment of nondepressed psychiatric illness in elderly patients: a review of the literature. J Geriatr Psychiatry Neurol 2008; 21(1):3-11
19. Roa V, Lyketsos CG: The benefits and risks of ECT for patients with primary dementia who also suffer from depression. Int J pf Geriatr Psychiatry 2000; 15:729-735
20. van der Wurff FB, Stek ML, Hoogendijk WJ, et al: The efficacy and safety of ECT in depressed older adults: a literature review. Int J Geriatr Psychiatry 2003; 18(10):894-904
21. Roccaforte WH, Wengel SP, Burke WJ: ECT for screaming in dementia. Am J Geriatr Psychiatry 2000; 8(2):177
22. McDonald WM, Thompson TR: Treatment of mania in dementia with electroconvulsive therapy. Psychopharmacology Bull 2001; 35(2):72-82
23. Grant JE, Mohan SN: Treatment of agitation and aggression in four demented patients using ECT. J ECT 2001; 17(3):205-209
24. Sutor B, Rasmussen KG: Electroconvulsive therapy for agitation in Alzheimer disease: a case series. J ECT 2008; 24(3):239-241
25. American Psychiatric Association: Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington DC: American Psychiatric Association; 2000
26. Rosen J, Burgio L, Kollar M, et al: A User-friendly instrument for rating agitation in dementia patients. Am J Geriatr Psychiatry 1994; 2(1):52-59
27. Burns A, Lawlor B, Craig S: Assessment Scales in Old Age Psychiatry. London, England: Martin Dunitz Ltd.; 1999
28. Guy W: ECDEU Assessment Manual for Psychopharmacology, Revised 1976. Rockville, MD, National Institute of Mental Health, Psychopharmacology Research Branch, 1976; 217-222, 313-331
29. Linn BS, Linn MW, Gurel L: Cumulative illness rating scale. J Am Geriatr Soc 1968; 16(5):622-626
30. Miller MD, Paradis CF, Houck PR, et al: Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992; 41(3):237-248
31. Hudon C, Fortin M, Vanasse A: Cumulative Illness Rating Scale was a reliable and valid index in a family practice context. J Clin Epidemiol 2005; 58(6):603-608
32. O'Reardon JP, Takieddine N, Datto CJ, et al: Propofol for the management of emergence agitation after electroconvulsive therapy: review of a case series. J ECT 2006; 22(4):247-252
33. Geretsegger C, Nickel M, Judendorfer B, et al: Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. J ECT 2007; 23(4):239-243
34. Bang J, Price D, Prentice G, et al: ECT treatment for two cases of dementia-related pathological yelling. J Neuropsychiatry Clin Neurosci 2008; 20(3):379-380
35. Greenberg L, Fink M: The use of electroconvulsive therapy in geriatric patients. Clin Geriatr Med 1992; 8(2):349-354
36. Shub D, Ball V, Abbas AA, et al: The link between psychosis and aggression in persons with dementia: a systematic review. Psychiatr Q 2010; 81(2):97-110
37. Sachdev P, Kruk J: Restlessness: the anatomy of a neuropsychi-atric symptom. Aust N Z J Psychiatry 1996; 30(1):38-53
38. Mintzer JE, Brawman-Mintzer O: Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach. J Clin Psychiatry 1996; 57(suppl 7):55-63; discussion 73-75
39. Soininen H, MacDonald E, Rekonen M, et al: Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Acta Neurol Scand 1981; 64(2):101-107
40. Hardy J, Cowburn R, Barton A, et al: A disorder of cortical GABAer-gic innervation in Alzheimer's disease. Neurosci Lett 1987;14, 73(2):192-196
41. Michael N: Hypothesized mechanisms and sites of action, in Elec-troconvulsive and Neuromodulation Therapies. Edited by Swartz CM. New York, NY, Cambridge Unversity Press, 2009, pp 75-93
42. Eitan R, Landusht G, Lerer B: Neurochemical effects of electrically induced seizures, in Electroconvulsive and Neuromodula-tion Therapies. Edited by Swartz CM. New York, NY, Cambridge Unversity Press, 2009, pp 45-74
43. Devanand DP, Shapira B, Petty F, et al: Effects of electroconvulsive therapy on plasma GABA. Convuls Ther 1995; 11(1):3-13
44. Newman ME, Gur E, Shapira B, et al: Neurochemical mechanisms of action of ECS: evidence from in vivo studies. J ECT 1998; 14(3):153-171
45. Palmio J, Huuhka M, Saransaari P, et al: Changes in plasma amino acids after electroconvulsive therapy of depressed patients. Psychiatry Res 2005; 15, 137(3):183-190
46. Pfleiderer B, Michael N, Erfurth A, et al: Effective electrocon-vulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res 2003; 122(3):185-192
47. Tielkes CE, Comijs HC, Verwijk E, et al: The effects of ECT on cognitive functioning in the elderly: a review. Int J Geriatr Psychiatry 2008; 23(8):789-795
48. Stoudemire A, Hill CD, Morris R, et al: Long-term affective and cognitive outcome in depressed older adults. Am J Psychiatry 1993; 150(6):896-900